{"id":946173,"date":"2026-03-23T08:22:27","date_gmt":"2026-03-23T12:22:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-group-to-announce-fourth-quarter-and-full-year-2025-results-on-march-26-2026\/"},"modified":"2026-03-23T08:22:27","modified_gmt":"2026-03-23T12:22:27","slug":"22nd-century-group-to-announce-fourth-quarter-and-full-year-2025-results-on-march-26-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/22nd-century-group-to-announce-fourth-quarter-and-full-year-2025-results-on-march-26-2026\/","title":{"rendered":"22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026"},"content":{"rendered":"
\n

\n MOCKSVILLE, N.C., March 23, 2026 (GLOBE NEWSWIRE) — <\/strong>22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Thursday, March 26, 2026, at 8:00 AM ET to discuss its 2025 fourth quarter and full year results, which are to be reported in a press release at 6:00 AM ET the same day.<\/p>\n

During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results, discuss progress made in the recent months and update plans for the 2026 year.<\/p>\n

The live and archived webcast will be accessible on the Events web page in the Company’s Investor Relations section of the website, at https:\/\/ir.xxiicentury.com\/events<\/u><\/a>. Please access the website at least 10 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.<\/p>\n

\n About 22nd Century Group, Inc.<\/b>\u00a0<\/p>\n

22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption.\u00a0<\/p>\n

\n Our Technology is Tobacco<\/b>\n <\/p>\n

Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement.\u00a0<\/p>\n

\n Our Products<\/b>\n <\/p>\n

We created our flagship product, the VLN\u00ae<\/sup>\u202fcigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN\u00ae<\/sup>\u202fcigarettes have 95% less nicotine compared to traditional cigarettes and have been proven to allow consumers to\u00a0greatly reduce\u00a0their nicotine consumption.\u00a0<\/p>\n

\n FDA Authorization and Scientific Foundation<\/b>\u00a0<\/p>\n

VLN\u00ae<\/sup>\u202flow nicotine combustible cigarettes were authorized in December 2021, making them the first and still the only combustible cigarettes authorized by the U.S. Food and Drug Administration specifically to help reduce nicotine consumption.\u00a0<\/p>\n

Decades of independent clinical research and peer-reviewed studies\u2014evaluated as part of the FDA\u2019s Modified Risk Tobacco Product (MRTP) authorization process\u2014demonstrated\u00a0that reducing nicotine content can decrease nicotine intake, increase quit attempts, and reduce overall exposure to nicotine.\u00a0<\/p>\n

FDA-authorized VLN\u00ae<\/sup>\u202fclaims include:\u00a0<\/p>\n